Growth Metrics

Fulgent Genetics (FLGT) Other Accumulated Expenses (2016 - 2026)

Fulgent Genetics' Other Accumulated Expenses history spans 8 years, with the latest figure at $2.5 million for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses fell 42.04% to $2.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.5 million, a 42.04% decrease, with the full-year FY2025 number at $2.8 million, down 21.66% from a year prior.
  • Other Accumulated Expenses hit $2.5 million in Q1 2026 for Fulgent Genetics, down from $2.8 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for FLGT hit a ceiling of $13.6 million in Q3 2022 and a floor of $281000.0 in Q3 2023.
  • Historically, Other Accumulated Expenses has averaged $3.7 million across 5 years, with a median of $3.6 million in 2024.
  • Biggest five-year swings in Other Accumulated Expenses: plummeted 97.94% in 2023 and later skyrocketed 1345.55% in 2024.
  • Tracing FLGT's Other Accumulated Expenses over 5 years: stood at $2.1 million in 2022, then surged by 97.52% to $4.2 million in 2023, then dropped by 13.78% to $3.6 million in 2024, then dropped by 21.66% to $2.8 million in 2025, then decreased by 13.07% to $2.5 million in 2026.
  • Business Quant data shows Other Accumulated Expenses for FLGT at $2.5 million in Q1 2026, $2.8 million in Q4 2025, and $6.9 million in Q3 2025.